- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 491/14
Total number of patents in this class: 194
10-year publication summary
|
27
|
19
|
12
|
9
|
13
|
3
|
19
|
13
|
13
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5831 |
13 |
| Amgen Inc. | 4074 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2571 |
5 |
| F. Hoffmann-La Roche AG | 7925 |
4 |
| Genentech, Inc. | 3976 |
4 |
| Gilead Sciences, Inc. | 2036 |
4 |
| Jubilant Biosys Limited | 20 |
4 |
| Fundacion Del Sector Publico Estatal Centro Nacional de Investigaciones Oncologicas Carlos III (f.s.p. Cnio) | 61 |
4 |
| Sudo Biosciences Limited | 26 |
4 |
| Novartis AG | 10849 |
3 |
| LG Chem, Ltd. | 17632 |
3 |
| Samsung SDI Co., Ltd. | 8319 |
3 |
| Epizyme, Inc. | 370 |
3 |
| Incyte Corporation | 1024 |
3 |
| Rigel Pharmaceuticals, Inc. | 539 |
3 |
| Rutgers, The State University of New Jersey | 1895 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2851 |
3 |
| Veiled Therapeutics, LLC | 11 |
3 |
| Convalife (Shanghai) Co., Ltd. | 17 |
3 |
| Samsung Electronics Co., Ltd. | 146092 |
2 |
| Other owners | 115 |